Literature DB >> 16442565

The probable structure of the protamine-DNA complex.

Ken Biegeleisen1.   

Abstract

A detailed molecular structure is proposed for the human protamine-DNA complex, which has hitherto been largely a mystery. The structure was created with virtual modeling software (AmiraMol), employing logical deduction as the primary investigative tool. A beta-sheet structure for the protein component is essentially mandated, as the alternatives can be decisively excluded. A dimeric structure too is essentially mandated, since the cysteine residues of protamines P1 and P2 are invariably aligned in all species having both chains. The cross-sectional and axial spacings of arginine guanidinium groups in this protein structure can be perfectly aligned with those of phosphate groups in DNA according to the DNA structure proposed by Wu. This is a non-helical structure, whose possible occurrence in certain plasmids has been suggested by experimental observations. The unit cell of this protamine-DNA complex is essentially devoid of steric hindrances, and heavily favored by a multitude of ionic and hydrogen bonds. The packing of adjacent "unit cells" of the protamine-DNA structure is based on a complex array of salt bridges, the mere existence of which is so fortuitous that it is virtually inconceivable that it comes about through a mere modeling "coincidence". The possible significance of the structure beyond the sperm cell is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442565     DOI: 10.1016/j.jtbi.2005.12.015

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  12 in total

Review 1.  Proteomics and the genetics of sperm chromatin condensation.

Authors:  Rafael Oliva; Judit Castillo
Journal:  Asian J Androl       Date:  2010-11-01       Impact factor: 3.285

Review 2.  Epigenetics and the dynamics of chromatin during adenovirus infections.

Authors:  Kelsey L Lynch; Linda R Gooding; Charlie Garnett-Benson; David A Ornelles; Daphne C Avgousti
Journal:  FEBS Lett       Date:  2019-12-15       Impact factor: 4.124

3.  Nanovectorization of DNA Through Cells Using Protamine Complexation.

Authors:  Khaoula Boukari; Cécile Caoduro; Raoudha Kacem; Nadia Skandrani; Christophe Borg; Hatem Boulahdour; Tijani Gharbi; Régis Delage-Mourroux; Eric Hervouet; Marc Pudlo; Fabien Picaud
Journal:  J Membr Biol       Date:  2016-03-24       Impact factor: 1.843

4.  pH-responsive biodegradable assemblies containing tunable phenyl-substituted vinyl ethers for use as efficient gene delivery vehicles.

Authors:  Hee-Kwon Kim; David H Thompson; Ho Seong Jang; Yong Jin Chung; Jeroen Van den Bossche
Journal:  ACS Appl Mater Interfaces       Date:  2013-06-17       Impact factor: 9.229

5.  ModeRNA: a tool for comparative modeling of RNA 3D structure.

Authors:  Magdalena Rother; Kristian Rother; Tomasz Puton; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2011-02-07       Impact factor: 16.971

6.  Biophysical Characterization of Human Protamine-1 as a Responsive CEST MR Contrast Agent.

Authors:  Nikita Oskolkov; Amnon Bar-Shir; Kannie W Y Chan; Xiaolei Song; Peter C M van Zijl; Jeff W M Bulte; Assaf A Gilad; Michael T McMahon
Journal:  ACS Macro Lett       Date:  2014-12-16       Impact factor: 6.903

7.  Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.

Authors:  Victor I Band; David S Weiss
Journal:  Antibiotics (Basel)       Date:  2015-03

8.  Protamines and spermatogenesis in Drosophila and Homo sapiens : A comparative analysis.

Authors:  Rachelle L Kanippayoor; Joshua H M Alpern; Amanda J Moehring
Journal:  Spermatogenesis       Date:  2013-04-01

Review 9.  Interpreting sperm DNA damage in a diverse range of mammalian sperm by means of the two-tailed comet assay.

Authors:  Elva I Cortés-Gutiérrez; Carmen López-Fernández; José Luis Fernández; Martha I Dávila-Rodríguez; Stephen D Johnston; Jaime Gosálvez
Journal:  Front Genet       Date:  2014-11-27       Impact factor: 4.599

10.  Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy.

Authors:  Aritz Pérez Ruiz de Garibay; Diego Delgado; Ana Del Pozo-Rodríguez; María Ángeles Solinís; Alicia Rodríguez Gascón
Journal:  Drug Des Devel Ther       Date:  2012-10-26       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.